Focused On LifeDeveloping novel therapies for serious diseases
Driven By ScienceRapid, efficient, cost-effective approach
Medivation, Inc. is a biopharmaceutical company focused on the development and commercialization of medically innovative therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families.
Medivation is proud to be a 2015 Top WorkplaceLearn More
November 6, 2015 Medivation Announces Participation at Upcoming Investor Conference Learn More
November 5, 2015 Medivation Reports Third Quarter 2015 Financial Results Learn More